结肠癌中长链非编码RNA LUCAT1水平与患者预后的关系及对结肠癌细胞迁移、侵袭的影响

程莉莉; 王琳; 董颖

doi:10.13201/j.issn.1004-2806.2021.02.003

结肠癌中长链非编码RNA LUCAT1水平与患者预后的关系及对结肠癌细胞迁移、侵袭的影响

- 如皋市人民医院检验科(江苏如皋, 226500)
基金项目:
南通市科研计划项目(No:WKZD2018029)

详细信息

通讯作者: 王琳,E-mail:fhsuwj@163.com

中图分类号: R735.3

收稿日期: 2020-07-08

Relationship between lncRNA LUCAT1 level in colon cancer and prognosis of patients and its effect on colon cancer cell migration and invasion

- Department of Laboratory Medicine, Rugao People's Hospital, Rugao, 226500, China

More Information

Corresponding author: WANG Lin, E-mail: fhsuwj@163.com

Received Date: 08 July 2020

摘要

摘要: 目的:分析结肠癌中长链非编码RNA (lncRNA)肺癌相关转录本1(LUCAT1)水平与患者预后的关系及对结肠癌细胞迁移、侵袭的影响。方法:选择2016年1月—2017年12月收治的行手术治疗的53例结肠癌患者作为研究对象,检测受试者肿瘤病灶组织和癌旁组织中lncRNA LUCAT1表达水平。取LoVo细胞检测分为空白组、阴性对照组、干预组,检测细胞增殖、迁移、侵袭活性。结果:肿瘤病灶组织中lncRNA LUCAT1水平明显高于癌旁组织,差异有统计学意义(P＜0.05);肿瘤病灶组织中lncRNA LUCAT1水平是影响患者总生存期和无进展生存期的独立性威胁因素(P＜0.05);低lncRNA LUCAT1表达患者总生存期和无进展生存期明显低于高lncRNA LUCAT1表达患者,差异有统计学意义(P＜0.05);24 h和48 h时空白组、阴性对照组和干预组LoVo细胞增殖活性存在明显差异,其中空白组最高,干预组最低,差异有统计学意义(P＜0.05);3组LoVo细胞迁移及侵袭活性存在明显差异,其中空白组迁移及侵袭活性最高,干预组最低,差异有统计学意义(P＜0.05)。结论:结肠癌肿瘤病灶组织中高lncRNA LUCAT1是影响患者预后质量的独立性威胁因素,且可促进结肠癌细胞迁移、侵袭。
- 结肠癌 /
- lncRNALUCAT1 /
- 预后 /
- 细胞迁移 /
- 细胞侵袭
Abstract: Objective: To analyze the relationship between the level of lncRNA LUCAT1 in colon cancer and the prognosis of patients and its impact on colon cancer cell migration and invasion.Methods: A total of 53 patients with colon cancer who underwent surgical treatment between January 2016 and December 2017 in our hospital were selected as the research object. The expression level of lncRNA LUCAT1 in the lesion tissue and adjacent tissue of the subject was detected. LoVo cell detection was divided into blank group, negative control group and intervention group, which were tested for cell proliferation, migration and invasion activity.Results: The level of lncRNA LUCAT1 in tumor tissue was significantly higher than that in adjacent tissues, and the difference was statistically significant(P＜0.05). The level of lncRNA LUCAT1 in tumor tissue was an independent threat factor that affected the overall survival and progression-free survival of patients(P＜0.05). The overall survival and progression-free survival of the patients with low lncRNA LUCAT1 expression were significantly lower than those with high lncRNA LUCAT1 expression, and the difference was statistically significant(P＜0.05). There were significant differences in the proliferation activity of LoVo cells among the blank group, negative control group and intervention group at 24 h and 48 h, among which the blank group was the highest and the intervention group was the lowest, and the difference was statistically significant(P＜0.05). There were obvious differences in LoVo cell migration and invasion activity among the blank group, negative control group and intervention group, among which the blank group had the highest migration and invasion activity, and the intervention group had the lowest, and the difference was statistically significant(P＜0.05).Conclusion: High lncRNA LUCAT1 in colon cancer lesion tissue might be an independent threat factor that could affect the prognostic quality of patients, and could promote colon cancer cell migration and invasion.
- colon cancer /
- lncRNA LUCAT1 /
- prognosis /
- cell migration /
- cell invasion

HTML全文

参考文献(15)

[1]	Bo H,Fan L,Li J,et al.High Expression of lncRNA AFAP1-AS1 Promotes the Progression of Colon Cancer and Predicts Poor Prognosis[J].J Cancer,2018,9(24):4677-4683.
[2]	Chow FC,Chok KS.Colorectal liver metastases:An update on multidisciplinary approach[J].World Journal of Hepatology,2019,11(2):150-172.
[3]	傅中懋,黄陈.“偏左,朝右”:基于原发部位结肠癌发生机制研究进展及临床治疗决策思辨[J].中华结直肠疾病电子杂志,2019,8(6):546-552.
[4]	Yin D,Lu X,Su J,et al.Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non-small cell lung cancer cell proliferation by epigenetically repressing p21 expression[J].Mol Cancer,2018,17(1):92.
[5]	Nai Y,Pan C,Hu X,et al.LncRNA LUCAT1 contributes to cell proliferation and migration in human pancreatic ductal adenocarcinoma via sponging miR-539[J].Cancer Med,2020,9(2):757-767.
[6]	Li X,Wang X,Mao L,et al.LncRNA TP73-AS1 predicts poor prognosis and promotes cell proliferation in ovarian cancer via cell cycle and apoptosis regulation[J].Mol Med Rep,2018,18(1):516-522
[7]	Liu T,Han Z,Li H,et al.LncRNA DLEU1 contributes to colorectal cancer progression via activation of KPNA3[J].Mol Cancer,2018,17(1):118.
[8]	肖维喜.浅析导致接受手术治疗的结肠癌患者术后病情复发或转移的危险因素[J].当代医药论丛,2019,17(7):58-60.
[9]	Qian P,Xu Z,Chen H,et al.Abnormally expressed lncRNAs in the prognosis and clinicopathology of oesophageal cancer:a systematic review and meta-analysis[J].J Genet,2020,99:43.
[10]	Yu J,Han Z,Sun Z,et al.LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway[J].J Exp Clin Cancer Res,2018,37(1):222.
[11]	Sun Y,Zeng C,Gan S,et al.LncRNA HOTTIP-Mediated HOXA11 Expression Promotes Cell Growth,Migration and Inhibits Cell Apoptosis in Breast Cancer[J].Int J Mol Sci,2018,19(2):472.
[12]	于贵林,林杰,赵国华,等.长链非编码RNA lucat1对胃癌细胞侵袭和迁移能力的影响及其机制[J].山东医药,2018,58(20):17-20.
[13]	Xiong Y,Wang J,Zhu H,et al.Chronic oxymatrine treatment induces resistance and epithelial mesenchymal transition through targeting the long non-coding RNA MALAT1 in colorectal cancer cells[J].Oncol Rep,2018,39(3):967-976.
[14]	Gao L,Cao H,Cheng X.A positive feedback regulation between long noncoding RNA SNHG1 and YAP1 modulates growth and metastasis in laryngeal squamous cell carcinoma[J].Am J Cancer Res,2018,8(9):1712-1724.
[15]	胡春艳,朱根海,邢艾文,等.LncRNA LUCAT1通过靶向miR-199a-5p调控宫颈癌细胞活性、侵袭迁移及其分子机制[J].中国老年学杂志,2019,39(13):3257-3261.